Organon & Co (OGN)
21.52
+0.17
(+0.80%)
USD |
NYSE |
May 15, 15:15
Organon Total Liabilities (Quarterly): 11.84B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.84B |
December 31, 2023 | 12.13B |
September 30, 2023 | 11.60B |
June 30, 2023 | 11.53B |
March 31, 2023 | 11.50B |
December 31, 2022 | 11.85B |
September 30, 2022 | 11.50B |
Date | Value |
---|---|
June 30, 2022 | 11.75B |
March 31, 2022 | 11.85B |
December 31, 2021 | 12.19B |
September 30, 2021 | 12.95B |
June 30, 2021 | 12.84B |
March 31, 2021 | 4.92B |
December 31, 2020 | 4.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.623B
Minimum
Dec 2020
12.95B
Maximum
Sep 2021
10.93B
Average
11.80B
Median
Total Liabilities (Quarterly) Benchmarks
Amgen Inc | 87.96B |
Merck & Co Inc | 65.42B |
Pfizer Inc | 128.54B |
Alnylam Pharmaceuticals Inc | 4.044B |
Moderna Inc | 3.912B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.89B |
Shareholders Equity (Quarterly) | 48.00M |
Debt to Equity Ratio | 181.54 |
Current Ratio | 1.649 |
Net Debt Paydown Yield | 0.83% |